Details of vaccine trading transactions between pharmaceutical companies and governments are largely secrets, due to the secret to keep the seller's secrets. Governments around the world are "pouring" USD billion for Pharmaceutical company to develop a vaccine of Covid-19, as well as other billions of dollars to buy vaccines. However, according to The New York Times, the details of these transactions are mostly secrets, due to the main Community and Community Health Organization accepts the requirements of pharmaceutical companies on keeping secrets. This agreement is said to make it difficult for the explanation, as in the case of two pharmaceutical companies Pfizer (USA) and Astrazeneca (UK) in January announcement cannot be delivered to the European Union (EU) true for the goal. The unknown things in the vaccine negotiations between pharmaceutical companies and governments
. Photo: REUTERSDO The terms of the contract kept confidential and strictly protected, the question or responsibility for the contracting parties is very difficult. Some existing documents shows that in the agreement , Pharmaceutical company is entitled to schedule flexible delivery and liability exemption if there is anything wrong. In some cases, the countries are banned or reselled vaccines, which are given It is possible to interfere with the financing effort to low-income countries
According to the New York Times, governments mainly access vaccines through three types of agreements: (i) Buy directly from firms pharmacy; (ii) buy through regional organizations such as the European Union (EU) or African Union (AU); (iii) Receive Vaccine through the Covax initiative. The Government supports the development of Vaccine Covid-19 according to the newspaper, because the development of potential vaccines has many risks, companies rarely invest in production, unless they Make sure its vaccines are effective and can be approved by the Government. This is one of the reasons for usually taking a lot of time to develop and distribute a vaccine. Attend that process, governments - mainly US and European countries, and groups Non-profit as creative alliances ready for epidemics (CEPI) - Accept risks to invest in NovavaX's vaccine development. Photo: REUTERTRY TO February, USA has spent about $ 1.6 billion to help Novavax company develop Vaccine Covid-19. CEPI also mobilized about $ 400 million to finance as well as for NovavaX interest-free loans. Such big grants are also provided to other pharmaceutical companies. Besides using technology do The government developed as a foundation for the company's vaccine, Moderna Pharmaceutical Company also received about $ 1 billion in funding from the US government to develop vaccines. These forms of support to help pharmaceutic companies start production Vaccine Covid-19 as well as covering clinical trial costs
Which side will hold a patent? According to The New York Times, Although receiving a large investment from the state budget, the patent on vaccines Regarding pharmaceutical companies, it means that these companies can decide how, where the production is as well as the price of the vaccine. CureVAC (Germany) explained in the contract, this company "will be Exclusively exploit any rights "For such inventions. This is considered a controversial issue for a long time. India and South Africa lead the Alliance Some countries recommended World Trade Organization (WTO) to abandon intellectual property rights so that mass pharmaceutic companies can also produce vaccines. Medical organization About (WHO) approved this idea, but all the above efforts failed due to facing opposition from the US and Europe, where patents and profits were obtained from selling vaccines to be traded Consider the "arterial of innovation". The difference in Covid-19 vaccine prices is in the main terms of the vaccine contract as the price per dose. According to the documentation that The New York Times collected, this detail is usually reduced in the public version of the contract. Pharmaceutical companies considers this to be a commercial secret. Some companies listed in the terms of terms allow them to temporarily stop supply if the countries reveal the price of the vaccine. However, even if the Government accepts this term, some information leaks Seeing the difference in the purchase price of vaccines in countries. The European Board pays 2.19 USD for each dose of vaccine produced by Oxford University (England) and Astrazeneca, while South Africa has doubled at 5.25 USD. This is the focus of the fact that the Belgian official in December 2020 has accidentally revealed the Vaccine price list, in which Americans have to pay $ 19.5 for each dose of Pfizer Vaccine, while Europeans Only pay 14.7 USD .Clusions and reselling Vaccinetheo The New York Times, activists for public health have urged high-income countries to sponsor or resell vaccines for poor countries. However, the terms of vaccine purchase contracts of pharmaceutical companies can limit this because of reducing their sales.Vaccine of Corevac. Photo: Aa.com.trví d . Dịch vụ:
Thiết kế website,
quảng cáo google,
đăng ký website bộ công thương uy tín
